Advertisement News Archives - Page 3031 of 5237 - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

September 18, 2026

Ona Therapeutics to develop ADC with WuXi’s payload-linker platform

WuXi XDC Cayman has signed an agreement to provide Ona Therapeutics with an exclusive global licence to its WuXiTecan-2 payload-linker technology platform for the development of an antibody-drug conjugate (ADC) candidate.

Ona Therapeutics to develop ADC with WuXi’s payload-linker platform